Martin Kullen (VP, Human Health Science & Innovation) and Jakob Dalmose Rasmussen (VP, Strategy, Portfolio & Marketing) discuss how Novonesis distinguishes its probiotics on the market, and additionally cover the company’s in-house capabilities.
Insight into the Development Process: This video provides a detailed understanding of the scientific research and clinical trials involved in developing Novonesis probiotics, highlighting the rigorous processes that ensure efficacy and safety.
Understanding the Impact and Differentiation: Learn how Novonesis probiotics interact with the human microbiome, particularly in the gut-brain axis, and why this is significant for consumers. Additionally, understand what sets these probiotics apart from competitors, including how they cater to diverse consumer preferences and regional needs.
Comprehensive Capabilities and Market Strategy: This video showcases the company's in-house capabilities spanning product design, clinical studies, regulatory compliance, and full-turn-key solutions. This comprehensive approach not only supports product innovation but also enhances market position and drives business growth through success stories and strategic execution.